BioSpace News Archive

Vapotherm, Inc., a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory distress, announced the commencement of a proposed public offering of $75 million of its shares of common stock.

Houston, TX (May 5, 2020) – Pulmotect, Inc., a clinical-stage biotechnology company, has received approval from the U.S. Food & Drug Administration (FDA) to initiate two COVID-19 Phase-2 clinical trials of its innate immune stimulating drug PUL-042.

INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced that it will host a conference call on May 14, 2020 at 4:30 PM Eastern Time to discuss results for its first quarter ended March 31, 2020.

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today reported business highlights and financial results for the first quarter of 2020.

Transcat, Inc., a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its fourth quarter and full fiscal year 2020 results after the close of financial markets on Tuesday, May 19, 2020.

Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) today reported results for the quarter ended March 31, 2020.

DongWha Pharm (KRX:000020), a leading Korean pharmaceutical company, announced on April 21 st , 2020 that it plans to conduct clinical trials using a new drug candidate DW2008 to treat COVID-19. DW2008 is an extract of the water willow plant ( Justicia procumbens ). In vitro antiviral experiments performed at the Institut Pasteur Korea against COVID-19 demonstrate

PinCell, a biotechnology company developing novel therapies for rare dermatological diseases, announced today the appointment of Gabriella Camboni, M.D., as Chief Executive Officer of PinCell and Member of the Board of Directors, and Luigi Costa as Chairman of the Board

To meet the challenge of ensuring adequate food for the vulnerable senior population, whose needs have greatly increased due to the COVID-19 pandemic, Conviva Care Centers have stepped up to provide a donation of $2 million to support seven local Feeding America® member food banks in Florida and Texas.

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced approval of ELYXYB (celecoxib oral solution 25 mg/mL) by the U.S. Food and Drug Administration (USFDA). ELYXYB (previously known as DFN-15) is indicated for the acute treatment of migraine with or without aura in adults.